Efficacy of Treatment for Somatoform Disorders: A Review of Randomized Controlled Trials
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To review the evidence from randomized clinical trials (RCTs) that have focused on the treatment of patients with Diagnostic and Statistical Manual of Mental Disorders, 4(th) Edition (DSM-IV) somatoform disorders. Although somatoform disorders are among the most common mental disorders presenting in the general medical setting, the strength of evidence for specific treatments has not been well synthesized. METHODS: MEDLINE search of articles published in English from 1966 to 2006, using the following search terms: randomized clinical trial, somatoform disorders, somatization disorder, undifferentiated somatoform disorder, hypochrondriasis, conversion disorder, pain disorder, and body dysmorphic disorder. RESULTS: A total of 34 RCTs involving 3922 patients were included. Two thirds of the studies involved somatization disorder (n = 4 studies) and lower threshold variants, such as abridged somatization disorder (n = 9) and medically unexplained symptoms (n = 10). Cognitive behavioral therapy (CBT) was effective in most studies (11 of 13), as were antidepressants in a small number (4 of 5) of studies. RCTs examining a variety of other treatments showed benefit in half (8 of 16) of the studies, the most consistent evidence existing for a consultation letter to the primary care physician. Effective treatments have been established for all somatoform disorders except conversion disorder (1 of 3 studies showing benefit) and pain disorder (no studies reported). CONCLUSION: CBT is the best established treatment for a variety of somatoform disorders, with some benefit also demonstrated for a consultation letter to the primary care physician. Preliminary but not yet conclusive evidence exists for antidepressants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00008 · Cited by 3,298
Self-citationUtility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,635
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401 · cited 1×
“8 or greater are considered large therapeutic effects (61).”
BackgroundUtility of a New Procedure for Diagnosing Mental Disorders in Primary Care: The PRIME-MD 1000 Study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.1994.03520220043029 · Cited by 1,873
Summing up: The Science of Reviewing Research
Wilkinson, I., Light, R. J., & Pillemer, D. B. (1987) · Journal of Educational Statistics · doi:10.2307/1164691 · Cited by 1,471
Summing Up: The Science of Reviewing Research
Light, R. J., & Pillemer, D. B. (1984) · Harvard University Press eBooks · doi:10.4159/9780674040243 · Cited by 1,427
Barsky, A. J., Orav, E. J., & Bates, D. W. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.903 · Cited by 911
Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta-Analytic Review
Henningsen, P., Zimmermann, T., & Sattel, H. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000075977.90337.e7 · Cited by 829
Ormel, E. A. (1995) · PsycEXTRA Dataset · doi:10.1037/e536912011-072 · Cited by 706
Cited by
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
“The search of reference lists of 24 reviews or meta-analyses (Allen 2002; Atkinson 1985; Decoutere 2011; Escobar 1996; Fallon 2004; Fishbain 1998; Gildenberg 1984; Grothe 2004; Jackson 2000; Jackson 2006a; Jackson 2006b; Kroenke 2007; Lynch 2001; Magni 1991; Marks 2009; McQuay 1995; O’Malley 1999; Price 2000; Prior 20…”
BackgroundKroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
“However, recent reviews have identified effective pharmacological and behavioral interventions [150–152].”
BackgroundSelf-citationThe Somatic Symptom Scale–8 (SSS-8): A Brief Measure of Somatic Symptom Burden
Gierk, B., Kohlmann, S., Kroenke, K., Spangenberg, L., Zenger, M., Brähler, E., & Löwe, B. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12179 · Cited by 740
Self-citationDepression, anxiety and somatization in primary care: Syndrome overlap and functional impairment
Löwe, B., Spitzer, R. L., Williams, J. B. W., Mussell, M., Schellberg, D., & Kroenke, K. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.01.001 · Cited by 706
“However, multiple studies [59–61] demonstrate that effective treatment of depression, anxiety and somatization improves functional status.”
BackgroundSelf-citationMind the gap: improving the dissemination of CBT
Shafran, R., Clark, D. M., Fairburn, C. G., Arntz, A., Barlow, D. H., Ehlers, A., Freeston, M., Garety, P. A., Hollon, S. D., Ost, L. G., et al. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.07.003 · Cited by 569
“(Kroenke, 2007) and schema-focused therapy and dialectical behaviour therapy are both effective for borderline personality disorder”
BackgroundCognitive-behavioral therapy for psychogenic nonepileptic seizures: A pilot RCT
Goldstein, L. H., Chalder, T., Chigwedere, C., Khondoker, M. R., Moriarty, J., Toone, B. K., & Mellers, J. D. C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e39658 · Cited by 477
Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?
Phillips, K. A., Stein, D. J., Rauch, S. L., Hollander, E., Fallon, B. A., Barsky, A., Fineberg, N., Mataix-Cols, D., Ferrão, Y. A., Saxena, S., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20705 · Cited by 347
“Similar to HYP and OCD, CBT has been shown to be efficacious for syndromal and subsyndomal SD, although specific strategies vary by disorder.([301,311]) There are no controlled pharmacologic studies of SD, but controlled studies of somatization using a less restrictive set of criteria (multisomatoform disorder) yielde…”
ResultFink, P., & Schröder, A. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.02.004 · Cited by 334
“Finally, the bodily distress syndrome diagnosis may have the potential to facilitate patient care given that very similar treatments have been shown to be effective in various functional somatic syndromes [47–51] and somatoform disorders [19,52,53].”
BackgroundKocalevent, R.-D., Hinz, A., & Brähler, E. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-91 · Cited by 307
“Reviews have identified effective behavioural and pharmacological interventions for somatoform disorders [42-45], and guidelines are close to be published (e.”
BackgroundManagement of psychogenic nonepileptic seizures
LaFrance, W. C., Reuber, M., & Goldstein, L. H. (2013) · Epilepsia · doi:10.1111/epi.12106 · Cited by 316
“Cognitive behavioral therapy The most substantial body of data relates to the application of cognitive behavioral therapy (CBT), which has been shown to be effective in the treatment of a range of somatoform disorders (Kroenke, 2007; Hopp & LaFrance, 2012) and is being extended in brief self-help format for patients w…”
Backgroundvan Dessel, N., den Boeft, M., van der Wouden, J. C., Kleinstäuber, M., Leone, S. S., Terluin, B., Numans, M. E., van der Horst, H. E., & van Marwijk, H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011142.pub2 · Cited by 302
Short-Term Psychodynamic Psychotherapy for Somatic Disorders
Abbass, A., Kisely, S., & Kroenke, K. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000228247 · Cited by 280
Self-citationSomatic symptom disorder: an important change in DSM
Dimsdale, J. E., Creed, F., Escobar, J., Sharpe, M., Wulsin, L., Barsky, A., Lee, S., Irwin, M. R., & Levenson, J. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.06.033 · Cited by 239
“These include primarily cognitive therapy, a range of behavioral techniques (including relaxation training and mindfulness), other psychotherapies, and in some cases psychotropic medications [33].”
BackgroundCampo, J. V. (2012) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2012.02535.x · Cited by 229
The epidemiology of multiple somatic symptoms
Creed, F. H., Davies, I., Jackson, J., Littlewood, A., Chew-Graham, C., Tomenson, B., Macfarlane, G., Barsky, A., Katon, W., & McBeth, J. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.01.009 · Cited by 224
“Reviewing all of the risk factors for a high total somatic symptom count with individual patients should enable treatment to be focussed on the relevant factors with a view to making it more effective [30,76].”
BackgroundKleinstäuber, M., Witthöft, M., & Hiller, W. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.09.001 · Cited by 212
Guided self-help for functional (psychogenic) symptoms: A randomized controlled efficacy trial
Sharpe, M., Walker, J., Williams, C., Stone, J., Cavanagh, J., Murray, G., Butcher, I., Duncan, R., Smith, S., & Carson, A. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c0c7 · Cited by 211
Psychological Approaches to Origins and Treatments of Somatoform Disorders
Witthöft, M., & Hiller, W. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131505 · Cited by 171
Sattel, H., Lahmann, C., Gündel, H., Guthrie, E., Kruse, J., Noll-Hussong, M., Ohmann, C., Ronel, J., Sack, M., Sauer, N., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.093526 · Cited by 160
“,8–10 Against this background we conducted a large, multicentre, randomised controlled trial to test the efficacy of a manualised brief psychodynamic interpersonal psychotherapy (PIT), a variant of psychodynamic therapy with particular emphasis on inter-personal processes, 11 not limited to one…”
Dimsdale, J., & Creed, F. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.03.005 · Cited by 159
Globus pharyngeus: A review of its etiology, diagnosis and treatment
Lee, B. E. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i20.2462 · Cited by 154
Non-Specific, Functional, and Somatoform Bodily Complaints
Schaefert, R., Hausteiner-Wiehle, C., Häuser, W., Ronel, J., Herrmann, M., & Henningsen, P. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0803 · Cited by 153
“A consultation/care recommendation letter provided to the primary care physician (information about the patient’s illness and specific recommendations for treatment including assessment wether inpatient or day clinic treatment is indicated [Box 3]), which may if necessary be repeated, leads to improvement in the level…”
BackgroundLiu, J., Gill, N. S., Teodorczuk, A., Li, Z.-J., & Sun, J. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.114 · Cited by 145
Fjorback, L. O., Arendt, M., Ørnbøl, E., Walach, H., Rehfeld, E., Schröder, A., & Fink, P. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.09.006 · Cited by 144
“These disorders are considered by many clinicians to be among the most frustrating disorders to manage, and levels of patient dissatisfaction are reported to be high [4,5].”
BackgroundToussaint, A. C., Löwe, B., Brähler, E., & Jordan, P. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.03.017 · Cited by 157
Functional (conversion) neurological symptoms: research since the millennium
Carson, A. J., Brown, R., David, A. S., Duncan, R., Edwards, M. J., Goldstein, L. H., Grunewald, R., Howlett, S., Kanaan, R., Mellers, J., et al. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301860 · Cited by 143
Pediatric Somatic Symptom Disorders
Malas, N., Ortiz‐Aguayo, R., Giles, L. L., & Ibeziako, P. I. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0760-3 · Cited by 150
Multidisciplinary treatment for functional neurological symptoms: a prospective study
Demartini, B., Batla, A., Petrochilos, P., Fisher, L., Edwards, M. J., & Joyce, E. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7495-4 · Cited by 130
“In fact, it has been widely described that patients with FNS have a high frequency of relapse or chronicity of the symptoms [25, 26].”
BackgroundManaging difficult encounters: understanding physician, patient, and situational factors.
Lorenzetti, R. C., Jacques, C. H. M., Donovan, C. L., Cottrell, S. A., & Buck, J. (2013) · PubMed · Cited by 157
Bodily distress syndrome: a new diagnosis for functional disorders in primary care?
Budtz-Lilly, A., Schröder, A., Rask, M. T., Fink, P., Vestergaard, M., & Rosendal, M. (2015) · BMC Family Practice · doi:10.1186/s12875-015-0393-8 · Cited by 115
“These include exercise, psychological treatment, information and structured care [25, 46, 79–81].”
Background(2016) · PubMed · Cited by 113
Kroenke, K., Zhong, X., Theobald, D., Wu, J., Tu, W., & Carpenter, J. S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.337 · Cited by 113
Self-citationEdwards, T. M., Stern, A., Clarke, D. D., Ivbijaro, G., & Kasney, L. M. (2010) · PubMed Central · Cited by 185
Axelsson, E., & Hedman-Lagerlöf, E. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1703182 · Cited by 96
Fink, P., & Rosendal, M. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f51254 · Cited by 106
Williams, G. C., Halvari, H., Niemiec, C. P., Sørebø, Ø., Olafsen, A. H., & Westbye, C. (2014) · Work & Stress · doi:10.1080/02678373.2014.971920 · Cited by 104
“Somatization is estimated to cost US$256 billion per year in health care utilization and lost job productivity in the USA (Barsky, Orav, & Bates, 2005), as employees with somatization often report disability, miss work, seek medical care and undergo testing to confirm or exclude physical illness (De Gucht & Fischler,…”
BackgroundEffectiveness of psychotherapy for severe somatoform disorder: meta-analysis
Koelen, J. A., Houtveen, J. H., Abbass, A., Luyten, P., Eurelings-Bontekoe, E. H. M., Van Broeckhuysen-Kloth, S. A. M., Bühring, M. E. F., & Geenen, R. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.121830 · Cited by 104
Gierk, B., Kohlmann, S., Toussaint, A. C., Wahl, I., Brünahl, C. A., Murray, A., & Löwe, B. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.11.006 · Cited by 119
“Because somatic symptoms are related to impaired functioning, decreased health related quality of life, increased health care service use and psychological distress [3,4,7,9,10], the assessment of somatic symptomburden is essential in evidence based patient care and research [11–13].”
BackgroundKroenke, K., Monahan, P. O., & Kean, J. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.03.023 · Cited by 100
“For example, patients who report multiple somatic symptoms can be recognized as having somatization or a somatoform disorder which in turn have evidence-based treatments.(51) In such cases, a somatic symptom composite score may even be more useful than multiple individual itemlevel symptom scores.”
BackgroundSelf-citationCognitive–behavioural group treatment for a range of functional somatic syndromes: Randomised trial
Schröder, A., Rehfeld, E., Ørnbøl, E., Sharpe, M., Licht, R. W., & Fink, P. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.098681 · Cited by 95
Zonneveld, L. N. L., Sprangers, M. A. G., Kooiman, C. G., Spijker, A. V. ’., & Busschbach, J. J. V. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-520 · Cited by 113
“An implementation of cognitive-behavioral therapy in medical settings seems to be rational, because cognitivebehavioral therapy is the most effective treatment [48,63,64].”
BackgroundResultClarke, D. M., Piterman, L., Byrne, C. J., & Austin, D. W. (2008) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb02180.x · Cited by 94
Sogutlu, A., Levenson, J. L., McClish, D. K., Roseff, S. D., & Smith, W. R. (2011) · Psychosomatics · doi:10.1016/j.psym.2011.01.010 · Cited by 105
Somatic symptom burden and health anxiety in the population and their correlates
Lee, S., Creed, F. H., Ma, Y.-L., & Leung, C. M. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.11.012 · Cited by 89
Conversion disorder: advances in our understanding
Feinstein, A. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110490 · Cited by 87
Inpatient treatment of functional motor symptoms: a long-term follow-up study
Saifee, T. A., Kassavetis, P., Pareés, I., Kojović, M., Fisher, L., Morton, L. B., Foong, J., Price, G. W., Joyce, E. M., & Edwards, M. J. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6530-6 · Cited by 85
Feltz-Cornelis, C. M. V. D., Hoedeman, R., Keuter, E., & Swinkels, J. A. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.11.007 · Cited by 95
“Level A Evidence was found for effectiveness of psychiatric consultation to GPs as well as for Occupational Health Physicians (OHPs) [10,11], for effectiveness of CBT in general practice as well as mental health settings [12], for the use of a consultation letter to the GP in MUPS [13], and for a stepped care approach…”
BackgroundRask, M. T., Ørnbøl, E., Rosendal, M., & Fink, P. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000405 · Cited by 81
“Somatoform disorders and functional somatic syndromes may be treated effectively with combinations of cognitive behavioral therapy, antidepressants, graded exercise, and relaxation techniques (52,53).”
BackgroundApproach to the Patient with Multiple Somatic Symptoms
Croicu, C., Chwastiak, L., & Katon, W. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.007 · Cited by 81
“CBT has the strongest and most consistent evidence for its efficacy among different psychotherapeutic modalities.(66,75) In a review of 13 randomized controlled trials (RCTs) of treatment modalities for somatoform disorders, Kroenke showed that CBT was effective in most studies (supported by 11 of 13 RCTs).”
BackgroundA Review of Body Dysmorphic Disorder and Its Presentation in Different Clinical Settings
Mufaddel, A., Osman, O. T., Almugaddam, F., & Jafferany, M. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12r01464 · Cited by 79
Refinement of anxiety sensitivity measurement: the short scale anxiety sensitivity index (SSASI)
Zvolensky, M. J., Garey, L., Fergus, T. A., Gallagher, M. W., Viana, A. G., Shepherd, J. M., Mayorga, N. A., Kelley, L. P., Griggs, J. O., & Schmidt, N. B. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.115 · Cited by 74
“The PHQ-15 is considered a preferred measure to assess for the severity of somatic symptoms (Kroenke, 2007).”
BackgroundThe impact of somatic symptoms on the course of major depressive disorder
Bekhuis, E., Boschloo, L., Rosmalen, J. G. M., de Boer, M. K., & Schoevers, R. A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.030 · Cited by 94
“Psychological treatment (e.g., cognitive behavioral therapy) may be a reasonable addition as it also targets both depressive and somatic symptoms (Campbell et al., 2003; Kroenke, 2007).”
BackgroundMental health: the new frontier for labour economics
Layard, R. (2013) · IZA Journal of Labor Policy · doi:10.1186/2193-9004-2-2 · Cited by 105
“But a meta-analysis of 13 US trials showed that CBT reduced these illnesses in all but two trials – and lowered the associated costs (Kroenke (2007)).”
Kompoliti, K., Wilson, B. C., Stebbins, G. T., Bernard, B. A., & Hinson, V. K. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.018 · Cited by 77
Enhanced care by generalists for functional somatic symptoms and disorders in primary care
Rosendal, M., Blankenstein, A. H., Morriss, R., Fink, P., Sharpe, M., & Burton, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008142.pub2 · Cited by 76
“Cognitive behavioural therapy provided to patients given a diagnosis by specially trained professionals has shown an effect in several trials (Kroenke 2007; Sumathipala 2007), whereas the evidence is limited with regard to effectiveness of CBT and psychosocial interventions provided by front line GPs seeing and caring…”
BackgroundTreatment of Functional (Psychogenic) Movement Disorders
Ricciardi, L., & Edwards, M. J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0246-x · Cited by 86
“The role of CBT as treatment for somatoform disorders is fairly well established [23].”
BackgroundIbeziako, P., Brahmbhatt, K., Chapman, A., De Souza, C., Giles, L., Gooden, S., Latif, F., Malas, N., Namerow, L., Russell, R., et al. (2019) · Hospital Pediatrics · doi:10.1542/hpeds.2018-0205 · Cited by 75
Heijmans, M., olde Hartman, T. C., van Weel-Baumgarten, E., Dowrick, C., Lucassen, P. L. B. J., & van Weel, C. (2011) · Family Practice · doi:10.1093/fampra/cmr004 · Cited by 75
Biological and perceived stress in motor functional neurological disorders
Apazoglou, K., Mazzola, V., Wegrzyk, J., Frasca Polara, G., & Aybek, S. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.08.023 · Cited by 72
“The dualism that the cause had to be either psychological or physical (a so-called “organic” neurological condition) has been resolved and FND is now considered a neuropsychiatric condition (Carson, 2014): it manifests with neurological symptoms that are linked to (and not caused by) psychological risk and/or maintain…”
Cognitive behavioral therapy for somatoform disorders
Allen, L. A., & Woolfolk, R. L. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.014 · Cited by 70
Role of psychiatric comorbidity in chronic Lyme disease
Hassett, A. L., Radvanski, D. C., Buyske, S. G., Savage, S. V., Gara, M. A., Escobar, J. I., & Sigal, L. H. (2008) · Arthritis Care & Research · doi:10.1002/art.24314 · Cited by 71
Limits to truth-telling: Neurologists’ communication in conversion disorder
Kanaan, R., Armstrong, D., & Wessely, S. C. (2009) · Patient Education and Counseling · doi:10.1016/j.pec.2009.05.021 · Cited by 74
“The diagnoses are seen as woefully inadequate [23], so that some have called for the distinctions to be dropped [24], and, in any case, there is little evidence for effective treatment of any of the three [25,26].”
BackgroundSchaefert, R., Kaufmann, C., Wild, B., Schellberg, D., Boelter, R., Faber, R., Szecsenyi, J., Sauer, N., Guthrie, E., & Herzog, W. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000343652 · Cited by 70
Psychogenic pseudosyncope: diagnosis and management
Raj, V., Rowe, A. A., Fleisch, S. B., Paranjape, S. Y., Arain, A. M., & Nicolson, S. E. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2014.05.003 · Cited by 69
“There are no RCTs studying the effects of psychotropic medications in patients with PPS (Kroenke, 2007).”
Backgroundvan Ravesteijn, H., Lucassen, P., Bor, H., van Weel, C., & Speckens, A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000348588 · Cited by 65
Zirke, N., Seydel, C., Szczepek, A. J., Olze, H., Haupt, H., & Mazurek, B. (2012) · Quality of Life Research · doi:10.1007/s11136-012-0156-0 · Cited by 72
“In case of comorbid somatoform or affective disorder, outpatient psychotherapy is recommended as particularly effective [43, 44].”
Leaviss, J., Davis, S., Ren, S., Hamilton, J., Scope, A., Booth, A., Sutton, A., Parry, G., Buszewicz, M., Moss-Morris, R., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24460 · Cited by 61
“62 2 (24) 3 (16) 7 (0) 2 (41) 5 (4) 4 (15) 6 (0)”
Psychopharmacotherapy of somatic symptoms disorders
Somashekar, B., Jainer, A. K., & Wuntakal, B. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2012.729758 · Cited by 65
“A systematic review (Kroenke, 2007) critically evaluated the evidence of treatment for somatoform disorder and identifi ed the paucity of sound research involving pharmacological agents.”
BackgroundNHG-Standaard Somatisch Onvoldoende verklaarde Lichamelijke Klachten (SOLK)
Hartman, T. O., Blankenstein, A. H., Molenaar, B., van den Berg, B. B., van der Horst, H. E., Arnold, I. A., Burgers, J. S., Wiersma, T., & Koch, H. (2013) · Huisarts en Wetenschap · Cited by 116
Somatoform Disorders and Recent Diagnostic Controversies
Kroenke, K. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.08.002 · Cited by 78
Self-citationCurrent status of HIV-1 diversity and drug resistance monitoring in the former USSR.
Mr, B. (2013) · PubMed · Cited by 62
Relationship between alexithymia and coping strategies in patients with somatoform disorder
Tominaga, T., Choi, H., Nagoshi, Y., Wada, Y., & Fukui, K. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s55956 · Cited by 75
Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy
Stacy, M. A., Murck, H., & Kroenke, K. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.023 · Cited by 66
Self-citationPsychogenic (Nonepileptic) Seizures
Krumholz, A., & Hopp, J. L. (2006) · Seminars in Neurology · doi:10.1055/s-2006-945520 · Cited by 60
Stein, D. J., & Muller, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016540 · Cited by 56
Informed Shared Decision-Making and Patient Satisfaction
Bot, A. G. J., Bossen, J. K. J., Herndon, J. H., Ruchelsman, D. E., Ring, D., & Vranceanu, A. (2014) · Psychosomatics · doi:10.1016/j.psym.2013.12.013 · Cited by 57
The neuropsychiatry of conversion disorder
Aybek, S., Kanaan, R., & David, A. S. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f94242 · Cited by 57
Maunder, R., Hunter, J., Atkinson, L. R., Steiner, M. S., Wazana, A. D., Fleming, A. S., Moss, E., Gaudreau, H., Meaney, M. J., & Levitan, R. D. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000437 · Cited by 61
“Existing treatments of somatization often provide partial relief (71).”
BackgroundConwill, M., Oakley, L., Evans, K., & Cavanna, A. E. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.03.012 · Cited by 55
“Psychotherapy, CBT in particular, is known to be beneficial for somatoform disorders in general [26–28], and preliminary evidence from trials examining CBT or CBT-based approaches for specific FNSs supports its efficacy for this patient population [10,11].”
Somatization and Health Anxiety as Predictors of Health Care Use
Tomenson, B., McBeth, J., Chew-Graham, C. A., MacFarlane, G., Davies, I., Jackson, J., Littlewood, A., & Creed, F. H. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31825cb140 · Cited by 51
de Vroege, L., Timmermans, A., Kop, W. J., & van der Feltz-Cornelis, C. M. (2018) · Psychological Medicine · doi:10.1017/s0033291717003300 · Cited by 50
“CBT is the most frequently used therapy for treating the psychological disorder in SSRD patients (Kroenke, 2007) but the effectivity of this treatment may be influenced negatively by neurocognitive dysfunctioning (i.”
MethodAdvances in understanding illness anxiety.
Harding, K. J., Skritskaya, N., Doherty, E., & Fallon, B. A. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0050-1 · Cited by 50
Guglani, L., Atkinson, S., Hosanagar, A., & Guglani, L. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00082 · Cited by 51
Early maladaptive schemas in depression and somatization disorder
Davoodi, E., Wen, A., Dobson, K. S., Noorbala, A. A., Mohammadi, A., & Farahmand, Z. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.017 · Cited by 48
Somatization and somatic symptom presentation in cancer: A neglected area
Grassi, L., Caruso, R., & Nanni, M. G. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2012.731384 · Cited by 46
“We need more data about the feasibility and cost-effectiveness of the protocols that are usually applied in primary care for somatoform disorders (Kroenke, 2007; Mayou, 2007).”
BackgroundStone, L. (2014) · BMC Family Practice · doi:10.1186/s12875-014-0192-7 · Cited by 62
“Many of these patients have significant functional impairment [3,4] with similar disability to patients with depression or anxiety [5-7].”
BackgroundPedersen, C., Halvari, H., & Olafsen, A. H. (2019) · Journal of Occupational Health Psychology · doi:10.1037/ocp0000131 · Cited by 51
Psychosocial interventions for conversion and dissociative disorders in adults
Ganslev, C. A., Storebø, O. J., Callesen, H. E., Ruddy, R., & Søgaard, U. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005331.pub3 · Cited by 44
Updated Review on the Diagnosis and Primary Management of Psychogenic Nonepileptic Seizure Disorders
Lanzillotti, A. I., Sarudiansky, M., Lombardi, N., Korman, G. P., & D´Alessio, L. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s286710 · Cited by 56
Hybelius, J., Kosic, A., Salomonsson, S., Wachtler, C., Wallert, J., Nordin, S., & Axelsson, E. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.46603 · Cited by 55
Primary care physicians treat somatization
Smith, R. C., Gardiner, J. C., Luo, Z., Schooley, S., Lamerato, L., & Rost, K. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0992-y · Cited by 41
Payne, H., & Stott, D. (2010) · Counselling and Psychotherapy Research · doi:10.1080/14733140903551645 · Cited by 40
“Regarding the efficacy of treatment for somatoform disorders, Kroenke (2007) stated in his review of randomized controlled trials that CBT seemed to be the best established treatment for somatoform disorders.”
BackgroundCreed, F. H., Kroenke, K., Henningsen, P., Gudi, A., & White, P. D. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977862.004 · Cited by 40
Self-citationHyphantis, T. N., Tomenson, B., Bai, M., Tsianos, E. V., Mavreas, V. G., & Creed, F. H. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0762-z · Cited by 51
“Therefore, the addition of treatment modalities focusing on somatization, such as cognitive therapy [54], psychodynamic interpersonal therapy [55] or antidepressants [53, 54], may help patients with IBD to improve their health-related quality of life.”
BackgroundSchröder, A., & Fink, P. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.05.008 · Cited by 39
Development of cognitive-behavioral therapy intervention for patients with Dhat syndrome
Prakash, O., Salam, K. M. A. E., & Sharma, M. (2012) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.104826 · Cited by 43
“[12,13] The efficacy of CBT in the treatment of psychosexual dysfunction has also been proved.”
Menon, V., Rajan, T. M., Kuppili, P. P., & Sarkar, S. (2017) · Indian Journal of Psychological Medicine · doi:10.4103/ijpsym.ijpsym_17_17 · Cited by 39
“[13‐16] However, as pointed out by Kroenke,[15] results from FSS may not necessarily extrapolate to the spectrum of somatoform disorders.”
BackgroundCognitive behavioral therapy for psychogenic movement disorder
LaFrance, W. C., Jr., & Friedman, J. H. (2009) · Movement Disorders · doi:10.1002/mds.22683 · Cited by 39
Czachowski, S., Piszczek, E., Sowińska, A., & Hartman, T. O. (2011) · Family Practice · doi:10.1093/fampra/cmr065 · Cited by 45
Kranick, S. M., Gorrindo, T., & Hallett, M. (2011) · Psychosomatics · doi:10.1016/j.psym.2010.12.017 · Cited by 42
Metadata
- Authors
- Kroenke, K.
- Affiliations
- Regenstrief Institute (US)
- Corresponding author
- Kroenke, Kurt
- ORCID
- Kroenke, Kurt
- Venue
- Psychosomatic Medicine
- Published
- 2007-11
- Volume
- 69
- Issue
- 9
- Pages
- 881-888
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2004606740
- Cited by
- 450
- References
- 68
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 10 · 2023: 4 · 2022: 13 · 2021: 14 · 2020: 16 · 2019: 20 · 2018: 25 · 2017: 39 · 2016: 26 · 2015: 22 · 2014: 40 · 2013: 48 · 2012: 41
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- somatoform disorders, somatization disorder, medically unexplained symptoms, health anxiety, conversion disorder, pain disorders, body dysmorphic disorder, cognitive behavioral therapy, antidepressants, treatment efficacy
- MeSH terms
- Antidepressive Agents, Body Image, Combined Modality Therapy, Conversion Disorder, Delusions, Hypochondriasis, Primary Health Care, Somatoform Disorders, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.